The Reply

Affiliations

¹ Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Md. Electronic address: david.graham1@fda.hhs.gov.
² Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Md.
³ Acumen LLC, Burlingame, Calif.
⁴ Centers for Medicare & Medicaid Services, Washington, DC.

Comment

David J Graham et al. Am J Med. 2019 Oct.

. 2019 Oct;132(10):e754-e755.

doi: 10.1016/j.amjmed.2019.06.046.

¹ Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Md. Electronic address: david.graham1@fda.hhs.gov.
² Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Md.
³ Acumen LLC, Burlingame, Calif.
⁴ Centers for Medicare & Medicaid Services, Washington, DC.

No abstract available

Comment on

Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
Graham DJ, Baro E, Zhang R, Liao J, Wernecke M, Reichman ME, Hu M, Illoh O, Wei Y, Goulding MR, Chillarige Y, Southworth MR, MaCurdy TE, Kelman JA. Graham DJ, et al. Am J Med. 2019 May;132(5):596-604.e11. doi: 10.1016/j.amjmed.2018.12.023. Epub 2019 Jan 9. Am J Med. 2019. PMID: 30639551
Appropriate Interpretation of the Observed NOACs Treatment Effect Size in Real-world Study.
Wang Y, Chen T, Dodd J, Li W. Wang Y, et al. Am J Med. 2019 Oct;132(10):e752-e753. doi: 10.1016/j.amjmed.2019.05.030. Epub 2019 Jul 19. Am J Med. 2019. PMID: 31331614 No abstract available.